IRF1 and inflammatory bowel disease: Beyond supporting our results from the aforementioned clodronate liposome or anti-CSF-1R experiments, showing myeloid-specific contributions of Carinh to colitis, these findings suggest that myeloid-specific disruption of both Carinh and Irf1 causes IBD pathology.